West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,600
Employees10,600
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,600
Employees10,600

WST Key Statistics

Market cap
19.37B
Market cap19.37B
Price-Earnings ratio
39.46
Price-Earnings ratio39.46
Dividend yield
0.32%
Dividend yield0.32%
Average volume
710.28K
Average volume710.28K
High today
$275.56
High today$275.56
Low today
$264.92
Low today$264.92
Open price
$266.46
Open price$266.46
Volume
689.63K
Volume689.63K
52 Week high
$348.90
52 Week high$348.90
52 Week low
$187.43
52 Week low$187.43

Stock Snapshot

The current West Pharmaceutical Services(WST) stock price is $269.13, with a market capitalization of 19.37B. The stock trades at a price-to-earnings (P/E) ratio of 39.46 and offers a dividend yield of 31.9%.

During the trading session on 2025-12-17, West Pharmaceutical Services(WST) shares reached a daily high of $275.56 and a low of $264.92. At a current price of $269.13, the stock is +1.6% higher than the low and still -2.3% under the high.

Trading volume for West Pharmaceutical Services(WST) stock has reached 689.63K, versus its average volume of 710.28K.

The stock's 52-week range extends from a low of $187.43 to a high of $348.90.

The stock's 52-week range extends from a low of $187.43 to a high of $348.90.

WST News

Simply Wall St 4d
West Pharmaceutical Services Valuation Check After 19% Year-to-Date Share Price Decline

West Pharmaceutical Services (WST) has been drifting lower this year, and with the stock down about 19% year to date, investors are starting to revisit the stor...

West Pharmaceutical Services Valuation Check After 19% Year-to-Date Share Price Decline
TipRanks 6d
West Pharmaceutical upgraded to Buy from Hold at Nephron Research

Nephron Research upgraded West Pharmaceutical (WST) to Buy from Hold with a $367 price target Published first on TheFly – the ultimate source for real-time, ma...

Analyst ratings

80%

of 20 ratings
Buy
80%
Hold
20%
Sell
0%

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.